---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-012236"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T10:42:07.163901+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences stockholders approve amended equity plan adding 3.34M shares

## Summary
- Stockholders approved A&R 2021 Equity Incentive Plan on Jan 24, 2025; 2.19M for, 0.47M against, 1.38M abstain.
- Plan adds 3,340,000 shares to reserve plus up to 44,093 from forfeited prior plan awards.
- Plan authorizes grants of options, SARs, restricted stock, RSUs, performance awards to employees, directors, consultants.
- Plan prohibits Exchange Programs (no repricing or cancellation of underwater awards without shareholder approval).

## SEC filing metadata
- accession: 0001193125-25-012236
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312525012236/0001193125-25-012236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312525012236/d875887d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-012236
- JSON: https://secwatch.observer/filing/0001193125-25-012236.json
- Plain text: https://secwatch.observer/filing/0001193125-25-012236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.